Categories: All posts

Donald Trump has failed America, Joseph Stiglitz says

Donald Trump has failed America with his response to the COVID-19 pandemic, says Nobel Prize-winning economist Joseph Stiglitz.

The COVID-19 pandemic is putting a strain on the medical system and governments should either do more to support essential services or face the dire economic consequences.

So says Stiglitz, who is now a Columbia University professor. He argues that in failing to act quickly the US government is causing the deaths of many citizens unnecessarily.

The shortage of medical equipment and protective gear for healthcare workers is becoming a key issue in the fight against the coronavirus, as the push comes to get more manufacturers involved in the production of face shields, masks and the ventilators needed to keep the infected alive.

Here in Canada, new reports from the Ontario government have said that one in four intensive care unit beds is now being occupied by COVID-19 patients, while in BC, the provincial health officer is saying that gloves and masks are being used up more quickly than previously thought.

“He failed and as a result of that, there are going to be many, many deaths unnecessary deaths,” said Stiglitz.

“It's a challenge that we have nine long-term-care facility outbreaks where additional protections are needed in those facilities, And then we now have increasing numbers of people in hospital, and that is going through way more personal protective equipment than we expected,” said Dr. Bonnie Henry, BC’s provincial health officer, in a briefing last week.

The link between economic and social health has never been displayed quite so graphically, with governments worldwide trying to support faltering businesses even as the virus has yet to peak in many Western countries. Stiglitz says that in the US, the federal government has been too slow on the draw, causing both more economic pain and likely more COVID-19 tragedies.

“One of the things that is astounding in a market economy is the shortages of essential materials that have showed up — shortages of tests, shortages a masks, shortages of ventilators shortages of protective gear. And it is very clear that the market economy not only did not make adequate provision of this before the crisis is not responding,” said Stiglitz, former chief economist at the World Bank, speaking to BNN Bloomberg on Friday.

Stiglitz: ““One of the things that is astounding in a market economy is the shortages of essential materials that have showed up…”

“In the United States, we have a law that gives the federal government the powers to actually compel the production of these goods. Those powers, should be used. It's a little late, President Trump should have done that three months ago. He failed and as a result of that, there are going to be many, many deaths unnecessary deaths,” said Stiglitz.

One of the things that the US federal government neglected in its major aid package, the $2-trillion relief bill signed into law last week, according to Stiglitz, is doing more to help businesses keep workers on the payroll so that healthcare benefits are maintained.

“It’s especially important in the United States because employees depend on health insurance that is provided by their employer. It’s not such a big issue in Canada but in the United States maintaining that nexus between the worker and his employers is really important,” Stiglitz said.

“There were some big gaps, [for example], inadequate provision of assistance to the States, and Governor Cuomo in New York has been particularly and I think rightfully critical of that major deficiency, which is a threat both to our economy but also to our health because the states in the end are responsible for providing health care in the United States,” Stiglitz added.

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

CHAR Technologies wins price target raise from this analyst

On Oct. 22, Paradigm Capital analyst Marvin Wolff raised his target on CHAR Technologies (CHAR Technologies Stock Quote, Chart, News,… [Read More]

24 hours ago

Can ATS stock bounce back?

Stifel analyst Justin Keywood maintained his “Buy” rating and $44.00 target on ATS Corporation (ATS Corporation  Stock Quote, Chart, News,… [Read More]

1 day ago

Three Canadian stocks analysts think could double

Markets have been choppy, but billionaire investor Bill Ackman sees the potential for a much stronger backdrop in 2027. Speaking… [Read More]

1 day ago

Atlas Engineered Products: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $1.00 target on Atlas Engineered Products (Atlas Engineered Products Stock… [Read More]

1 day ago

Atrium Therapeutics is a buy, this analyst says

Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA)… [Read More]

2 days ago

Texas Instruments is the anti-data center stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid says Texas Instruments (Texas Instruments Stock Quote, Chart, News, Analysts, Financials NASDAQ:TXN)… [Read More]

2 days ago